Abstract
This study examined the associations of increased glial fibrillary acidic protein (GFAP) levels and hypertrophie changes with susceptibility to toxic insult in C6 rat glioma cells. The cells were treated with serial pulses of dibutyryl-cAMP (dBcAMP) (each 48 hr) which increased levels of GFAP approximately twofold and the surface to volume ratio by approximately 1.7 times after the third pulse. This treatment reduced cell number by 22% and increased total protein by 10%. The cells were then exposed to different toxic substances [tin chloride, lead tetraacetate, chloroquine, cadmium chloride, aluminium chloride, mercuric chloride, acrylamide, triethyltin bromide, ethylenediaminetetraacetatic acid (EDTA)] and toxicity to the cells measured by the neutral red (NR) assay. With the exceptions of aluminium chloride and EDTA, 50% effective concentration (EC(50)) values for the toxic substances were increased up to 10,000 times (for cadmium chloride). Very similar increases in protection against the substances following dBcAMP treatment were found with the 1321N1 human astrocytoma cell line. We conclude that two components of gliosis, hypertrophy and increased GFAP, are associated with increased protection against a range of known neur...Continue Reading
References
Sep 15, 1978·Brain Research·H K KimelbergR S Bourke
Jun 1, 1979·Journal of Neurochemistry·C Nissen, A Schousboe
Sep 1, 1992·Neurochemical Research·W T NortonC F Brosnan
Jan 1, 1991·Glia·G Le PrinceM Tardy
Nov 1, 1991·Cell Proliferation·V MaresG Bottiroli
Jan 1, 1991·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·A Bruinink, P Reiser
Jul 1, 1987·Neuroscience·S FedoroffV I Kalnins
Sep 8, 1987·Brain Research·B A MacVicar
Jan 1, 1988·Glia·B A MacVicar, F W Tse
Jan 1, 1986·Brain Research·D L Davies, A Vernadakis
Jan 1, 1989·Journal of Neurochemistry·M TardyJ Nunez
Jan 1, 1987·Journal of Neuroscience Research·S K Sharma, A B Raj
Jan 1, 1985·Developmental Neuroscience·B H Juurlink, L Hertz
Jan 1, 1984·Journal of Neuroscience Research·S FedoroffR M Devon
Dec 14, 1984·Science·B A MacVicar
Apr 1, 1994·Trends in Neurosciences·M K McMillianK R Pennypacker
Feb 1, 1995·Neurochemistry International·J P O'CallaghanD B Miller
Jul 1, 1994·Brain Pathology·L F Eng, R S Ghirnikar
May 1, 1993·Journal of Neuropathology and Experimental Neurology·F WandosellM Nieto-Sampedro
Feb 15, 1993·Journal of Neuroscience Research·A C YuL F Eng
May 1, 1993·Neuroscience·M Eddleston, L Mucke
Jun 7, 2005·Expert Opinion on Drug Safety·James P O'Callaghan, Krishnan Sriram
Apr 1, 1977·Neuroscience Letters·G Moonen, G Franck
Jan 1, 1989·Neurochemistry International·C Charriere-BertrandJ Nunez
Jun 1, 1996·Toxicology in Vitro : an International Journal Published in Association with BIBRA·M R Cookson, V W Pentreath
Jun 1, 1994·Toxicology in Vitro : an International Journal Published in Association with BIBRA·M R Cookson, V W Pentreath
Apr 1, 1977·Neurochemical Research·A SchousboeG Svenneby
Citations
Sep 1, 2000·Chemico-biological Interactions·N D Slamon, V W Pentreath
Jul 6, 2014·BioMed Research International·Praveen KumarGurcharan Kaur
Jun 24, 2008·Critical Reviews in Toxicology·Edward J Calabrese
Jan 24, 2007·Toxicon : Official Journal of the International Society on Toxinology·A M M SilvaS L Costa
Jan 1, 2005·Nonlinearity in Biology, Toxicology, Medicine·N Debbie SlamonVic W Pentreath
Jan 1, 2004·Nonlinearity in Biology, Toxicology, Medicine·V W Pentreath, C Mead
Apr 25, 2008·Critical Reviews in Toxicology·Edward J Calabrese
Feb 24, 2001·Human & Experimental Toxicology·V W Pentreath, N D Slamon
Jan 18, 2018·Neurotoxicity Research·Victor Diogenes Amaral da SilvaSilvia Lima Costa
Mar 16, 2013·Archives of Toxicology·Verena J KollerSiegfried Knasmueller
Aug 17, 2021·CNS Neuroscience & Therapeutics·Chenyan SunZhaojin Wang